Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Moore, Kathleen
1967  Ergebnisse:
Personensuche X
?
1

Nivolumab with or without ipilimumab in patients with recur..:

Oaknin, Ana ; Moore, Kathleen ; Meyer, Tim...
The Lancet Oncology.  25 (2024)  5 - p. 588-602 , 2024
Link: https://doi.org/10.1016/..
 
?
2

The association of histopathologic features after neoadjuva..:

Mhawech-Fauceglia, Paulette ; McCarthy, Denis ; Tonooka, Akiko...
Gynecologic Oncology.  186 (2024)  - p. 17-25 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Developing a novel image marker to predict the clinical out..:

Zhang, Ke ; Abdoli, Neman ; Gilley, Patrik...
Computers in Biology and Medicine.  172 (2024)  - p. 108240 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Cervical cancer geographical burden analyzer: An interactiv..:

Castellano, Tara ; Moore, Kathleen ; Ting, Jie...
Gynecologic Oncology.  169 (2023)  - p. 113-117 , 2023
Link: https://doi.org/10.1016/..
 
?
5

VELA: A first-in-human phase 1/2 study of BLU-222, a potent..:

Yap, Timothy ; Patel, Manish ; Henick, Brian...
Gynecologic Oncology.  176 (2023)  - p. S173 , 2023
Link: https://doi.org/10.1016/..
 
?
6

ARTISTRY-7: A phase 3, multicenter study of nemvaleukin alf..:

Herzog, Thomas ; Hays, John ; Barlin, Joyce...
Gynecologic Oncology.  176 (2023)  - p. S189 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Veterans Treatment Courts: An Exploratory Analysis of the E..:

Gerhardt, T. Freeman ; Carlson, Melissa ; Moore, Kathleen A..
Criminal Justice Policy Review.  , 2023
Link: https://doi.org/10.1177/..
 
?
8

Association of Sialyl Tn antigen with cervical cancer lymph..:

Benbrook, Doris M. ; Deng, Wei ; Gold, Michael A....
Gynecologic Oncology.  171 (2023)  - p. 67-75 , 2023
Link: https://doi.org/10.1016/..
 
?
9

When a pandemic and epidemic collide: Lessons learned about..:

Sharp, Amanda ; Carlson, Melissa ; Vroom, Enya B....
Implementation Research and Practice.  4 (2023)  - p. , 2023
Link: https://doi.org/10.1177/..
 
?
10

ENGOT-EN20/GOG-3083/XPORT-EC-042 A phase 3, randomized, pla..:

Makker, Vicky ; Vergote, Ignace ; Mirza, Mansoor...
Gynecologic Oncology.  176 (2023)  - p. S156 , 2023
Link: https://doi.org/10.1016/..
 
?
11

A phase 2 study of dasatinib in recurrent clear cell carcin..:

O'Cearbhaill, Roisin E. ; Miller, Austin ; Soslow, Robert A....
Gynecologic Oncology.  176 (2023)  - p. 16-24 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Evaluating the Effectiveness of 2D and 3D CT Image Features..:

Abdoli, Neman ; Zhang, Ke ; Gilley, Patrik...
Bioengineering.  10 (2023)  11 - p. 1334 , 2023
Link: https://doi.org/10.3390/..
 
?
13

MIRASOL: A randomized, open-label, phase 3 study of mirvetu..:

Moore, Kathleen ; Konecny, Gottfried ; Martin, Lainie...
Gynecologic Oncology.  166 (2022)  - p. S156-S157 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Exploring tumor mutational burden status and clinical benef..:

Valente, Ana ; Gin, Amy ; Wells, Allison..
Gynecologic Oncology.  164 (2022)  1 - p. 3-4 , 2022
Link: https://doi.org/10.1016/..
 
?
15

MLH1 hypermethylation predicts poor outcomes with pembroliz..:

Borden, Lindsay ; Dvorak, Justin ; Barrett, Zachary...
Gynecologic Oncology.  166 (2022)  - p. S59 , 2022
Link: https://doi.org/10.1016/..
 
1-15